Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal oral physiology (HP:0031815)help
Parent Node:
expand
Abnormality of salivation (HP:0100755)help
..Starting node
..expand
Xerostomia (HP:0000217)help
Term ID: 217
Name: Xerostomia
Synonym: Decreased salivary flow; Dry mouth; Dry mouth syndrome; Reduced salivation
Definition: Dryness of the mouth due to salivary gland dysfunction.
Comments:
Reference: HP:0000217
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandExcessive salivation (HP:0003781) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000217HP:0000217Xerostomia0ANG CL E G H283483ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent32
HP:0000217HP:0000217Xerostomia0ANXA11 CL E G H311535ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent
HP:0000217HP:0000217Xerostomia0ATXN2 CL E G H631110555ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent11
HP:0000217HP:0000217Xerostomia0C9ORF72 CL E G H20322828337ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent56
HP:0000217HP:0000217Xerostomia0CAV1 CL E G H8571527ORPHA:220393Diffuse cutaneous systemic sclerosisHP:0040282 - Frequent11
HP:0000217HP:0000217Xerostomia0CCN2 CL E G H14902500ORPHA:220393Diffuse cutaneous systemic sclerosisHP:0040282 - Frequent
HP:0000217HP:0000217Xerostomia0CCNF CL E G H8991591ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent
HP:0000217HP:0000217Xerostomia0CCR6 CL E G H12351607ORPHA:220393Diffuse cutaneous systemic sclerosisHP:0040282 - Frequent
HP:0000217HP:0000217Xerostomia0CFAP410 CL E G H7551260ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent
HP:0000217HP:0000217Xerostomia0CHCHD10 CL E G H40091615559ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent11
HP:0000217HP:0000217Xerostomia0CHMP2B CL E G H2597824537ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent42
HP:0000217HP:0000217Xerostomia0CHRM3 CL E G H11311952OMIM:100100Prune belly syndrome.4
HP:0000217HP:0000217Xerostomia0CLDN10 CL E G H90712033OMIM:617671Helix syndrome3
HP:0000217HP:0000217Xerostomia0DAO CL E G H16102671ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent
HP:0000217HP:0000217Xerostomia0DCTN1 CL E G H16392711ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent86
HP:0000217HP:0000217Xerostomia0EDARADD CL E G H12817814341OMIM:614941Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive.56
HP:0000217HP:0000217Xerostomia0ELOVL1 CL E G H6483414418OMIM:618527Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features
HP:0000217HP:0000217Xerostomia0EPHA4 CL E G H20433388ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent4
HP:0000217HP:0000217Xerostomia0ERBB4 CL E G H20663432ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent15
HP:0000217HP:0000217Xerostomia0FGF10 CL E G H22553666OMIM:180920Aplasia of lacrimal and salivary glands.17
HP:0000217HP:0000217Xerostomia0FGF10 CL E G H22553666ORPHA:2363Lacrimoauriculodentodigital syndromeHP:0040282 - Frequent17
HP:0000217HP:0000217Xerostomia0FGF10 CL E G H22553666OMIM:149730Lacrimoauriculodentodigital syndrome.17
HP:0000217HP:0000217Xerostomia0FGFR2 CL E G H22633689OMIM:149730Lacrimoauriculodentodigital syndrome.175
HP:0000217HP:0000217Xerostomia0FGFR2 CL E G H22633689ORPHA:2363Lacrimoauriculodentodigital syndromeHP:0040282 - Frequent175
HP:0000217HP:0000217Xerostomia0FGFR3 CL E G H22613690OMIM:149730Lacrimoauriculodentodigital syndrome.145
HP:0000217HP:0000217Xerostomia0FGFR3 CL E G H22613690ORPHA:2363Lacrimoauriculodentodigital syndromeHP:0040282 - Frequent145
HP:0000217HP:0000217Xerostomia0FIG4 CL E G H989616873ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent111
HP:0000217HP:0000217Xerostomia0FUS CL E G H25214010ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent105
HP:0000217HP:0000217Xerostomia0GLE1 CL E G H27334315ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent45
HP:0000217HP:0000217Xerostomia0GLT8D1 CL E G H5583024870ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent
HP:0000217HP:0000217Xerostomia0GSN CL E G H29344620ORPHA:85448AGel amyloidosisHP:0040282 - Frequent53
HP:0000217HP:0000217Xerostomia0HLA-DRB1 CL E G H31234948ORPHA:220393Diffuse cutaneous systemic sclerosisHP:0040282 - Frequent2
HP:0000217HP:0000217Xerostomia0HNRNPA1 CL E G H31785031ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent31
HP:0000217HP:0000217Xerostomia0IRF5 CL E G H36636120ORPHA:220393Diffuse cutaneous systemic sclerosisHP:0040282 - Frequent4
HP:0000217HP:0000217Xerostomia0LBR CL E G H39306518ORPHA:779Reynolds syndromeHP:0040282 - Frequent70
HP:0000217HP:0000217Xerostomia0MAGEL2 CL E G H545516814ORPHA:398069MAGEL2-related Prader-Willi-like syndromeHP:0040283 - Occasional63
HP:0000217HP:0000217Xerostomia0MATR3 CL E G H97826912ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent80
HP:0000217HP:0000217Xerostomia0NEFH CL E G H47447737ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent24
HP:0000217HP:0000217Xerostomia0NEK1 CL E G H47507744ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent101
HP:0000217HP:0000217Xerostomia0NOD2 CL E G H641275331ORPHA:90340Blau syndromeHP:0040283 - Occasional187
HP:0000217HP:0000217Xerostomia0NOD2 CL E G H641275331OMIM:617321YAO SYNDROME; YAOS187
HP:0000217HP:0000217Xerostomia0OPTN CL E G H1013317142ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent62
HP:0000217HP:0000217Xerostomia0PFN1 CL E G H52168881ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent6
HP:0000217HP:0000217Xerostomia0PON1 CL E G H54449204ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent4
HP:0000217HP:0000217Xerostomia0PON2 CL E G H54459205ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent2
HP:0000217HP:0000217Xerostomia0PON3 CL E G H54469206ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent1
HP:0000217HP:0000217Xerostomia0PPARGC1A CL E G H108919237ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent1
HP:0000217HP:0000217Xerostomia0PRPH CL E G H56309461ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent25
HP:0000217HP:0000217Xerostomia0SCN9A CL E G H633510597OMIM:133020Erythermalgia, primary.318
HP:0000217HP:0000217Xerostomia0SIM1 CL E G H649210882ORPHA:398079SIM1-related Prader-Willi-like syndromeHP:0040283 - Occasional40
HP:0000217HP:0000217Xerostomia0SLC12A2 CL E G H655810911OMIM:619080KILQUIST SYNDROME; KILQS2
HP:0000217HP:0000217Xerostomia0SOD1 CL E G H664711179ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent53
HP:0000217HP:0000217Xerostomia0SQSTM1 CL E G H887811280ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent62
HP:0000217HP:0000217Xerostomia0TAF15 CL E G H814811547ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent
HP:0000217HP:0000217Xerostomia0TARDBP CL E G H2343511571ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent65
HP:0000217HP:0000217Xerostomia0TBK1 CL E G H2911011584ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent20
HP:0000217HP:0000217Xerostomia0TP63 CL E G H862615979OMIM:604292Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3.140
HP:0000217HP:0000217Xerostomia0TP63 CL E G H862615979ORPHA:1896EEC syndromeHP:0040283 - Occasional140
HP:0000217HP:0000217Xerostomia0TREM2 CL E G H5420917761ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent31
HP:0000217HP:0000217Xerostomia0UBQLN2 CL E G H2997812509ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent20
HP:0000217HP:0000217Xerostomia0UNC13A CL E G H2302523150ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent1
HP:0000217HP:0000217Xerostomia0VAPB CL E G H921712649ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent116
HP:0000217HP:0000217Xerostomia0VCP CL E G H741512666ORPHA:803Amyotrophic lateral sclerosisHP:0040282 - Frequent63


Genes (57) :ANG ANXA11 ATXN2 C9ORF72 CAV1 CCN2 CCNF CCR6 CFAP410 CHCHD10 CHMP2B CHRM3 CLDN10 DAO DCTN1 EDARADD ELOVL1 EPHA4 ERBB4 FGF10 FGFR2 FGFR3 FIG4 FUS GLE1 GLT8D1 GSN HLA-DRB1 HNRNPA1 IRF5 LBR MAGEL2 MATR3 NEFH NEK1 NOD2 OPTN PFN1 PON1 PON2 PON3 PPARGC1A PRPH SCN9A SIM1 SLC12A2 SOD1 SQSTM1 TAF15 TARDBP TBK1 TP63 TREM2 UBQLN2 UNC13A VAPB VCP

Diseases (19) :ORPHA:803 ORPHA:220393 OMIM:100100 OMIM:617671 OMIM:614941 OMIM:618527 OMIM:180920 ORPHA:2363 OMIM:149730 ORPHA:85448 ORPHA:779 ORPHA:398069 ORPHA:90340 OMIM:617321 OMIM:133020 ORPHA:398079 OMIM:619080 OMIM:604292 ORPHA:1896
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.